Back
Lyra Therapeutics, Inc. Stock Predictions
Valuation Up 5,000%. Shares Now $0.85 - Still Early?
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
23
LYRA
Lyra Therapeutics, Inc.
Last Price:
$3.60
Seasonality Move:
3.74%
7 Day Trial
ALL ACCESS PASS
$
7
Share Price Moved. Momentum Hasn't Slowed.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiLyra Therapeutics, Inc. Stock Forecast
-
Is Lyra Therapeutics, Inc. Stock Undervalued?The current Lyra Therapeutics, Inc. [LYRA] share price is $3.64. The Score for LYRA is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
-
LYRA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Lyra Therapeutics, Inc. Stock Go Up Next Year?
Data Unavailable
Lyra Therapeutics, Inc. Stock Rating
Data Unavailable
Lyra Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
lyratherapeutics.com
52-Week Data
52-Week High:
37.50
52-Week Low:
2.84
Prediction Charts
Market Cap:
4.8M
Price in USD:
3.64
Volume:
65.1K
Beta:
0.24
Technical Analysis
SMA50:
5.24
SMA100:
6.05
SMA200:
7.24
52-Wk Change:
-64.01%
Stock Predictions
-
Is Lyra Therapeutics, Inc. stock public?Yes, Lyra Therapeutics, Inc. is a publicly traded company.
-
What is the Lyra Therapeutics, Inc. stock quote today?The Lyra Therapeutics, Inc. stock price is 3.64 USD today.
-
How to buy Lyra Therapeutics, Inc. stock online?You can buy Lyra Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-24 | 3.23 | 3.05 | 3.28 | 3.03 |
| Nov-25 | 3.05 | 2.88 | 3.15 | 2.84 |
| Nov-26 | 2.95 | 3.50 | 4.16 | 2.95 |
| Nov-28 | 3.45 | 3.69 | 3.69 | 3.35 |
| Dec-1 | 3.78 | 3.73 | 3.80 | 3.60 |
| Dec-2 | 3.62 | 4.01 | 4.32 | 3.47 |
| Dec-3 | 4.07 | 4.19 | 4.32 | 3.94 |
| Dec-4 | 4.05 | 4.50 | 4.56 | 3.93 |
| Dec-5 | 4.50 | 4.27 | 4.59 | 4.25 |
| Dec-8 | 4.20 | 3.97 | 4.23 | 3.81 |
| Dec-9 | 3.97 | 3.96 | 4.15 | 3.79 |
| Dec-10 | 3.92 | 4.03 | 4.15 | 3.81 |
| Dec-11 | 3.84 | 4.00 | 4.12 | 3.84 |
| Dec-12 | 3.99 | 3.64 | 4.00 | 3.55 |
Lyra Therapeutics, Inc. Earnings
Data Unavailable
Lyra Therapeutics, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $62.25 per share, and an increase next year of $0.51 per share.
* Lyra Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.